Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Endocarditis II: Clinical features and Diagnostic Tests01:25

Endocarditis II: Clinical features and Diagnostic Tests

2
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
2
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

2
Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
2
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

2
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
2
Myocarditis II: Clinical features and Diagnostic Tests01:27

Myocarditis II: Clinical features and Diagnostic Tests

2
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
2
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

8
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
8
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

2
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
2

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Invasive candidiasis].

Revue medicale suisse·2024
Same author

Myeloid-Derived Suppressor-like Cells as a Prognostic Marker in Critically Ill Patients: Insights from Experimental Endotoxemia and Intensive Care Patients.

Cells·2024
Same author

Comparison of Three β-Glucan Tests for the Diagnosis of Invasive Candidiasis in Intensive Care Units.

Journal of clinical microbiology·2023
Same author

Anti-SARS-CoV-2 Titers Predict the Severity of COVID-19.

Viruses·2022
Same author

Sensitivity of Rapid Antigen Testing and RT-PCR Performed on Nasopharyngeal Swabs versus Saliva Samples in COVID-19 Hospitalized Patients: Results of a Prospective Comparative Trial (RESTART).

Microorganisms·2021
Same author

Implementing SARS-CoV-2 Rapid Antigen Testing in the Emergency Ward of a Swiss University Hospital: The INCREASE Study.

Microorganisms·2021

Related Experiment Video

Updated: Jun 11, 2025

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

9.0K

[Community-acquired Bacteremia: when should endocarditis be suspected?]

Julie Dudler1, Antonios Kritikos2

  • 1Service de médecine interne, HFR Fribourg, 1752 Villars-sur-Glâne.

Revue Medicale Suisse
|October 10, 2024
PubMed
Summary
This summary is machine-generated.

This study analyzes infective endocarditis (IE) risks from bacteremia, noting specific bacteria and patient factors increase IE likelihood. It proposes an algorithm to guide echocardiography decisions in high-risk bacteremia cases.

More Related Videos

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat
07:46

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat

Published on: June 4, 2012

15.7K
An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
07:50

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues

Published on: January 7, 2019

6.8K

Related Experiment Videos

Last Updated: Jun 11, 2025

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

9.0K
Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat
07:46

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat

Published on: June 4, 2012

15.7K
An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
07:50

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues

Published on: January 7, 2019

6.8K

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Microbiology

Context:

  • Guidelines from the European Society of Cardiology (ESC) and American Heart Association (AHA) lack species-specific recommendations for diagnosing infective endocarditis (IE).
  • Certain bacterial species and patient factors are known to elevate the risk of developing IE.
  • Community-acquired bacteremia presents a higher IE risk compared to nosocomial bacteremia.

Purpose:

  • To evaluate the risk of infective endocarditis (IE) associated with different bacterial species causing bacteremia.
  • To assess the impact of patient-specific factors, such as implantable electronic cardiovascular devices (IECD) and prior IE or valve surgery, on IE risk.
  • To propose a clinical evaluation algorithm integrating risk stratification systems (RSS) for guiding echocardiography in Gram-positive bacteremia.

Summary:

  • The article investigates IE risk stratification based on bacterial species in bacteremia, highlighting that while guidelines are general, specific bacteria (e.g., S. aureus, streptococci, enterococci) and conditions (community-acquired bacteremia, IECD, history of IE/valve surgery) increase risk.
  • Several risk stratification systems (RSS) exist to aid clinicians in determining the need for echocardiography in patients with Gram-positive bacteremia.
  • An evaluation algorithm is presented to assist in the clinical workup of patients with suspected IE.

Impact:

  • Provides a framework for clinicians to better assess IE risk in patients with bacteremia.
  • Aims to optimize the use of diagnostic tools like echocardiography by stratifying patient risk.
  • Contributes to improved diagnostic strategies for infective endocarditis, particularly in the context of Gram-positive bacteremia.